The SCTC is an international consortium representing the vast majority of researchers and clinicians who have particular interest and expertise in the care of, and research in, scleroderma (systemic sclerosis). The SCTC aims to represent the views and interests of its membership regarding the performance of clinical research in scleroderma. The SCTC strongly encourages international collaboration, inclusiveness in research groups, and involvement of trainees and junior faculty in all its activities.
Company Details
- Address
- Boston University School Of Medicine, Boston,massachusetts 02118,united States
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Boston.
- HQ
- Boston, Massachusetts
Scleroderma Clinical Trials Consortium, Inc. Questions
Scleroderma Clinical Trials Consortium, Inc.'s website is https://sclerodermaclinicaltrialsconsortium.org/
Scleroderma Clinical Trials Consortium, Inc.'s LinkedIn profile is https://www.linkedin.com/company/scleroderma-clinical-trials-consortium-inc
Scleroderma Clinical Trials Consortium, Inc.'s industry is
Research Services
Scleroderma Clinical Trials Consortium, Inc.'s top competitors are
Ai-Prognosis,
Scleroderma & Raynaud's Uk,
Scleroderma Research Foundation,
National Scleroderma Foundation,
Eustar_org,
Jane Nelson Institute For Women's Leadership,
Beaumont Independent School District,
World Scleroderma Foundation,
Iprolepsis,
Rairda.
Scleroderma Clinical Trials Consortium, Inc.'s categories are Research Services
